Revvity Stock

Revvity Debt

The Debt of Revvity (RVTY) as of Aug 23, 2026 is 3.22 B USD. In the previous year, Debt was 3.15 B USD — a change of 2.21% (higher).

Debt

3.22 BUSD

YoY

2.21%

Last updated:

In 2026, Revvity's total debt was 3.22 B USD, a 2.21% change from the 3.15 B USD total debt recorded in the previous year.

The Revvity Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
1.88 B USD
Jan 1, 2019
2.06 B USD
Jan 1, 2020
1.61 B USD
Jan 1, 2021
4.98 B USD
Jan 1, 2022
3.92 B USD
Jan 1, 2023
3.90 B USD
Jan 1, 2024
3.15 B USD
Jan 1, 2025
3.22 B USD
The Revvity Debt history
YEARDebtYoY
3.22 BUSD+2.21%
3.15 BUSD-19.21%
3.90 BUSD-0.60%
3.92 BUSD-21.21%
4.98 BUSD+209.36%
1.61 BUSD-22.01%
2.06 BUSD+9.99%
1.88 BUSD-6.46%
2.01 BUSD+91.92%
1.05 BUSD+3.31%
1.01 BUSD-3.21%
1.05 BUSD+12.16%
932.10 MUSD-0.71%
938.80 MUSD-0.65%
944.90 MUSD+121.65%
426.30 MUSD-23.64%
558.30 MUSD+9.69%
509.00 MUSD-1.49%
516.70 MUSD+44,713.53%
1.15 MUSD-99.53%
244.40 MUSD-34.76%
374.60 MUSD-31.83%
549.50 MUSD-31.79%
805.60 MUSD+539.45%
125.98 MUSD-31.20%
183.11 MUSD-63.16%
497.10 MUSD+72.78%
287.70 MUSD+78.58%
161.10 MUSD+649.30%
21.50 MUSD+305.66%
5.30 MUSD-91.17%
60.00 MUSD+37.61%
43.60 MUSD+3.07%
42.30 MUSD-29.03%
59.60 MUSD-37.66%
95.60 MUSD-8.52%
104.50 MUSD+205.56%
34.20 MUSD-57.57%
80.60 MUSD+28.34%
62.80 MUSD-19.59%
78.10 MUSD-19.23%
96.70 MUSD+493.25%
16.30 MUSD
Access this data via the Eulerpool API

Revvity Stock analysis

What does Revvity do? PerkinElmer Inc is an international company headquartered in Waltham, Massachusetts, USA. It provides solutions for improving health and the environment by offering instruments, consumables, software, and services in multiple industries. The company's history began in 1937 when Perkin-Elmer (named after two partners) was founded. It initially focused on manufacturing spectrometers and other instruments for chemical analysis. During World War II, Perkin-Elmer dramatically shifted its business towards the development of rocket sighting devices and aircraft parts. After the war, it returned to producing scientific equipment and began expanding into other markets. In the 1960s, Perkin-Elmer entered the field of medical diagnostics and started developing solutions for measuring hormones and proteins. Over the following decades, the company grew through expansion and acquisitions, including the purchase of Applied Biosystems, in areas such as molecular diagnostics, chromatography, genomics, and environmental analytics. PerkinElmer's business model focuses on providing solutions for customers in various fields such as pharma and biotechnology, environment and food, diagnostics, and clinical research. This includes instruments and consumables for analyzing proteins, nucleic acids, and other chemical substances, molecular diagnostic instruments and software, imaging systems for drug screening, and computer platforms for processing large amounts of data. The offered products and services of PerkinElmer encompass a wide range of solutions. The company's chromatography division offers instruments and consumables for the separation and analysis of chemical compounds. The Environmental Health division provides solutions for the identification and monitoring of pollutants in the environment, as well as for investigating food and drugs. The Analytical Sciences service division offers a wide range of analytical services to assist customers in solving research and development challenges. Other products and services of PerkinElmer include solutions for genomic analysis, drug development and manufacturing, diagnostic systems, laboratory automation, as well as software and services for data management. PerkinElmer is also a major provider of instruments and services in the field of medical imaging. One of PerkinElmer's standout products is its solutions for DNA and RNA sequencing. Using these technologies, researchers can identify genetic information that is crucial for disease diagnosis and treatment, as well as the development of new therapies and drugs. Overall, PerkinElmer offers a broad range of offerings aimed at improving health, the environment, and quality of life. The company works closely with customers in various industries to tailor its offerings to their needs. PerkinElmer is a key provider of solutions for improving health and the environment. The company offers a wide range of products and services, including instruments and consumables for chromatography, solutions for genomic analysis, and imaging systems for drug screening. Through its close collaboration with customers in various industries, PerkinElmer uses its knowledge and technology to make the world a better place. Revvity is one of the most popular companies on Eulerpool.

Debt Details

Understanding Revvity's Debt Structure

Revvity's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Revvity's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Revvity’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Revvity’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Revvity stock

Debt of Revvity is 3.22 B USD in 2026.

Debt of Revvity changed from 3.15 B USD to 3.22 B USD, representing a 2.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Revvity since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Revvity historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Revvity

All Key Metrics — Revvity